# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-15-002253
Filing Date
2015-03-31
Accepted
2015-03-31 09:35:16
Documents
20
Period of Report
2014-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | f10k2014_dandritbio.htm | 10-K | 1480711
2 | CERTIFICATION | f10k2014ex31i_dandritbio.htm | EX-31.1 | 9826
3 | CERTIFICATION | f10k2014ex31ii_dandritbio.htm | EX-31.2 | 9820
4 | CERTIFICATION | f10k2014ex32i_dandritbio.htm | EX-32.1 | 4321
11 | GRAPHIC | image_001.jpg | GRAPHIC | 6426
12 | GRAPHIC | image_002.gif | GRAPHIC | 5175
13 | GRAPHIC | image_002.jpg | GRAPHIC | 29567
14 | GRAPHIC | image_003.jpg | GRAPHIC | 28027
15 | GRAPHIC | image_004.jpg | GRAPHIC | 34408
16 | GRAPHIC | image_006.jpg | GRAPHIC | 50321
17 | GRAPHIC | image_007.jpg | GRAPHIC | 55684
18 | GRAPHIC | image_008.jpg | GRAPHIC | 15416
19 | GRAPHIC | image_009.jpg | GRAPHIC | 6099
20 | GRAPHIC | image_010.jpg | GRAPHIC | 7409
| Complete submission text file | 0001213900-15-002253.txt |  | 6250539

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL INSTANCE FILE | pmhs-20141231.xml | EX-101.INS | 638981
6 | XBRL SCHEMA FILE | pmhs-20141231.xsd | EX-101.SCH | 47896
7 | XBRL CALCULATION FILE | pmhs-20141231_cal.xml | EX-101.CAL | 53187
8 | XBRL DEFINITION FILE | pmhs-20141231_def.xml | EX-101.DEF | 96603
9 | XBRL LABEL FILE | pmhs-20141231_lab.xml | EX-101.LAB | 387338
10 | XBRL PRESENTATION FILE | pmhs-20141231_pre.xml | EX-101.PRE | 243811

Mailing Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7
Business Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7 45 39179840
DanDrit Biotech USA, Inc. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54478 | Film No.: 15736934
SIC: 2834 Pharmaceutical Preparations